Kortek Corporation (KOSDAQ:052330)
11,700
-410 (-3.39%)
At close: May 20, 2026
Kortek Revenue
In the year 2025, Kortek had annual revenue of 396.84B KRW with 28.85% growth. Kortek had revenue of 112.50B in the quarter ending December 31, 2025, with 42.38% growth.
Revenue
396.84B
Revenue Growth
+28.85%
P/S Ratio
0.38
Revenue / Employee
1.46B
Employees
280
Market Cap
150.79B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 396.84B | 88.85B | 28.85% |
| Dec 31, 2024 | 307.99B | -19.12B | -5.84% |
| Dec 31, 2023 | 327.11B | -101.45B | -23.67% |
| Dec 31, 2022 | 428.55B | 215.65B | 101.29% |
| Dec 31, 2021 | 212.91B | 26.38B | 14.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2011 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Kukbo Design | 438.89B |
| Intelligent Digital Integrated Security | 327.60B |
| KG Financial | 233.77B |
| Daihan Pharmaceutical | 208.61B |
| Synergy Innovation | 113.05B |
| T3 Entertainment | 69.51B |
| Vivozon Pharmaceutical | 59.34B |
| LS THiRA-UTECH | 58.94B |